Tag Archive for: STIMULAN

Biocomposites to host industry symposium and present new STIMULAN® data at EBJIS-MSIS 2026

/in

Industry symposium to explore local delivery of combination antibiotics across spine and arthroplasty Poster showcases the efficacy of STIMULAN® calcium sulfate beads, loaded with a combination of Gram-positive and Gram-negative antibiotics, against S. aureus biofilms Keele, UK, 9 September 2026 – Biocomposites, an international medical devices company that engineers, manufactures and markets world-leading products for […]

Read more

Biocomposites gains MDR certification for STIMULAN® Rapid Cure and STIMULAN® Kit

/in

STIMULAN® certified to be mixed with a combination of Gram-positive and Gram-negative antibiotics STIMULAN® certified to resolve infection and reduce the need for secondary surgery STIMULAN® is the only calcium matrix antibiotic carrier certified for use in bone and surrounding soft tissue Keele, UK, 5 February 2026 – Biocomposites, an international medical devices company that […]

Read more

Biocomposites announces expanded approval for STIMULAN® Rapid Cure to be mixed with antimicrobials to treat infection

/in

STIMULAN® Rapid Cure can now be used with both a wider range of antibiotics and also with antifungals in India STIMULAN® Rapid Cure can be placed in bone and surrounding soft tissue to assist in wound healing and treatment of infection Keele, UK, 25 November 2025 – Biocomposites, an international medical devices company that engineers, […]

Read more

Results from BIG D-FOOT study using STIMULAN® when treating DFO to be presented at EBJIS 2025

/in

Randomised, double-blinded, controlled BIG D-FOOT study demonstrates that local antibiotic delivery using STIMULAN® significantly reduces post-surgical infective complications in patients with diabetic foot osteomyelitis (DFO) Biocomposites symposium will explore best practice treatment strategies for complex infections and share findings from the BIG D FOOT study Keele, UK, 9 September 2025 – Biocomposites, an international medical […]

Read more

Biocomposites announces two new Phase II clinical trials of STIMULAN VG – a calcium matrix antibiotic carrier mixed with vancomycin and gentamicin – in the U.S.

/in

BLADE-VG2 trial will evaluate the safety and efficacy of STIMULAN VG to treat diabetic foot osteomyelitis BLADE-OPU2 will evaluate the safety and efficacy of STIMULAN VG to treat stage IV pressure ulcers Keele, UK, 7 February 2024 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management […]

Read more
© Optimum Strategic Communications.